R&D department operates in such fields as direct thrombin inhibitors, anticlotting agents, antineoplastic, antifungal, hepatoprotective and antiviral (incl. HIV) agents and drugs, as well as calcium metabolism regulators.
Our goal is to grow domestic production of socially critical preparations and thereby make quality and safe medicines available to wider audience.
We streamline our operations to comply with the requirements pronounced by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, and Q8.
We vigorously monitor the current level of drug quality requirements set by leading international organisations, foreign and domestic pharmacopoeias, and regulators in the Russian Healthcare Ministry to ensure competitive power of our drugs from the very start, i.e. at the R&D stage.
We apply methods of chromatographic control, verify our analytical techniques. We follow current trends and approaches to R&D in new products and reproduction of reference drugs.